Remus et al., Atherosclerosis 2013
:
These results demonstrate that miR181a regulates OPN expression and that altering miR181a expression may be a novel therapeutic approach to modulate OPN protein expression
Deng et al., Stem Cells Dev 2013
:
Overexpression of miR-31 significantly reduced expression of the osteogenic transcription factors OPN , BSP, OSX, and OCN, but not Runx2